Euroapi

Euroapi Capital Intensity

The Capital Intensity Ratio of Euroapi (EAPI.PA) as of Oct 17, 2026 is 153.82 %. In the previous year, Capital Intensity Ratio was 162.04 % — a change of -5.07% (lower).

Capital Intensity

153.82 %

YoY

-5.07%

Last updated:

Capital Intensity Ratio of Euroapi is 2025 153.82 % . Capital Intensity Ratio of Euroapi was 2024 162.04 % . It decreases by -5.07% lower compared to the previous year.

The Euroapi Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2019
172.17 EUR
Jan 1, 2020
169.49 EUR
Jan 1, 2021
181.28 EUR
Jan 1, 2022
176.99 EUR
Jan 1, 2023
158.25 EUR
Jan 1, 2024
162.04 EUR
Jan 1, 2025
153.82 EUR
The Euroapi Capital Intensity history
YEARCapital IntensityYoY
153.82 %-5.07%
162.04 %+2.40%
158.25 %-10.59%
176.99 %-2.37%
181.28 %+6.96%
169.49 %-1.55%
172.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Euroapi Stock analysis

What does Euroapi do? Euroapi SA, listed on EAPI.PA with ISIN FR0014008VX5, is a pharmaceutical company headquartered in Paris, France. The company went public on May 6, 2022, and currently employs 3,449 full-time staff. Euroapi specializes in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) for healthcare partners. Its product portfolio includes vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids, hormones, anti-infectives, opiates such as morphine, codeine, and thebaine, and analgesics. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering services such as Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones, and Opiates & Controlled Substances. Euroapi maintains production facilities across multiple European countries, including France, the United Kingdom, Germany, Italy, and Hungary. The company's website is www.euroapi.com, where further information about its services and operations can be found. Euroapi focuses on providing tailored API solutions to support the pharmaceutical industry's needs, emphasizing its role in the healthcare sector through its specialized manufacturing capabilities. Euroapi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Euroapi stock

Capital Intensity Ratio of Euroapi is 153.82 % in 2025.

Capital Intensity Ratio of Euroapi changed from 162.04 % to 153.82 %, representing a -5.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Euroapi since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Euroapi with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Euroapi

All Key Metrics — Euroapi